Pancreatic Cancer Research

ResearcherCatholic University of KoreaActive in the last 2 years

Ho Joong Choi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0862-098X; OpenAlex author ID A5091262049. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers

Papers 4

  1. Enhancing Pancreatic Cancer Therapy With Targeted CD133-Exosome Delivery of PD-L1 siRNA: A Preclinical Investigation. Co-author DOI 10.1097/mpa.0000000000002419↗
  2. Assessing the Efficacy of Mitochondria-Accumulating Self-Assembly Peptides in Pancreatic Cancer: An Animal Study. Co-author DOI 10.3390/ijms26020784↗
  3. Prognostic Implications of Portal Venous Circulating Tumor Cells in Resectable Pancreatic Cancer. Co-author DOI 10.3390/biomedicines10061289↗
  4. Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcinoma; a need to subclassify stage III? Co-author DOI 10.1016/j.ejca.2018.08.027↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Say‐June Kim · 2 shared papers, 2025 · strength 0.57
  2. Young Chul Yoon · 1 shared paper, 2025 · strength 0.30
  3. Moon Hyung Choi · 2 shared papers, 2018–2022 · strength 0.25
  4. In Seok Lee · 2 shared papers, 2018–2022 · strength 0.25
  5. Myung Ah Lee · 2 shared papers, 2018–2022 · strength 0.25
  6. Eun Sun Jung · 2 shared papers, 2018–2022 · strength 0.25
  7. Tae Ho Hong · 2 shared papers, 2018–2022 · strength 0.25
  8. Seung Bae Yoon · 2 shared papers, 2018–2022 · strength 0.25
  9. Young Hoon Choi · 1 shared paper, 2022 · strength 0.16
  10. Meiying Song · 1 shared paper, 2018 · strength 0.08
  11. Myung‐Gyu Choi · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.